Aclipse Therapeutics
Radnor
About Aclipse Therapeutics
Aclipse Therapeutics is a biopharmaceutical company that focuses on developing differentiated drugs to address diseases with unmet medical needs. Its strategy is reducing clinical development risk by combining a new and druggable understanding of disease pathways with a novel drug molecule that inhibits these pathways, allowing us to build upon existing nonclinical and clinical data while creating a significant patent barrier-to-entry.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: $1K – $10K
- Total funding: $5.6M
- Funding stage: Early Stage Venture
- Last round: Grant (Apr 2022)
- Website: aclipsetherapeutics.com
- Phone: [email protected]
Industries & Categories
Biotechnology, Medical, Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/aclipse-therapeutics-125410 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.